Likewise, in patients with morbid obesity, Vega-Badillo et al. reported that miR-33a/144 hepatic expression and their target ABCA1 are associated with NASH [143]. The gene discussed is ABCA1; the disease is metabolic dysfunction-associated steatohepatitis.